Medication Treatments | Addiction Professional Magazine Skip to content Skip to navigation

Medication Treatments

FDA approves once-monthly injectable buprenorphine product

December 1, 2017  |  Tom Valentino, Senior Editor
article
The FDA has approved a once-monthly injectable form of buprenorphine for the treatment of opioid use disorder, but clinicians are lukewarm on its use.

FDA seeks to encourage development of abuse-deterrent opioid formulations

November 24, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) this week announced several steps designed to remove barriers to access to abuse-deterrent formulations of opioids.

States eye adding gabapentin to controlled substance list

November 22, 2017  |  Rachael Zimlich, RN, Contributing Writer
article
Reports of increasing misuse of gabapentin, usually in combination with opioids or other drugs, have caught the attention of a number of state regulators.

Drug studies' results make case for access to all opioid dependence medications

November 16, 2017  |  Gary A. Enos, Editor
article
Recent efficacy and safety studies found comparable and encouraging results for buprenorphine and injectable naltrexone in the treatment of opioid dependence.

FDA clears electrical device to combat opioid withdrawal

November 15, 2017  |  Gary A. Enos, Editor
news
The Food and Drug Administration (FDA) today announced that an electrical stimulation device attached to the ear can be marketed for the treatment of symptoms of opioid withdrawal.

Hospital boosts opioid patients' rapid access to medication

November 14, 2017  |  Gary A. Enos, Editor
article
The experience of Boston Medical Center bolsters evidence that hospitalized patients with opioid use disorders can be successfully initiated on medication before discharge.

Record-setting amount of prescriptions collected on Take Back Day

November 7, 2017  |  Tom Valentino, Senior Editor
news
More than 456 tons of unwanted medications were collected for safe disposal during the U.S. Drug Enforcement Administration’s 14th Prescription Drug Take Back Day.

Injectable buprenorphine moves closer to approval

November 2, 2017  |  Gary A. Enos, Editor
news
It appears likely that the first monthly injectable formulation of buprenorphine to treat opioid dependence will receive federal approval by the end of this month.

Fact sheet on opioid treatments targets justice officials

October 27, 2017  |  Gary A. Enos, Editor
article
The American Association for the Treatment of Opioid Dependence (AATOD) seeks to separate ideology from evidence in discussing the importance of medication treatments in the justice system.

FDA doubles down on MAT

October 26, 2017  |  Julie Miller, Editor in Chief
news
The Food and Drug Administration announced that it is launching new efforts to discourage the prevailing resistance against the long-term use of medication assisted treatment for addiction.

Research seeks deeper understanding of how cocaine influences HIV

October 9, 2017  |  Gary A. Enos, Editor
news
A five-year research project could lead to more effective biomarkers for cocaine use and new therapeutic strategies for users with or without HIV.

Troncale urges rejection of extreme positions on role of medication treatment

October 3, 2017  |  Gary A. Enos, Editor
article
In his "If I were king" talk at the Moments of Change conference, the medical director at Retreat Premier Addiction Treatment Centers advocated a balanced and comprehensive approach to combating the opioid crisis.

Pages

Subscribe to Medication Treatments